JPWO2020178878A1 - - Google Patents

Info

Publication number
JPWO2020178878A1
JPWO2020178878A1 JP2021503235A JP2021503235A JPWO2020178878A1 JP WO2020178878 A1 JPWO2020178878 A1 JP WO2020178878A1 JP 2021503235 A JP2021503235 A JP 2021503235A JP 2021503235 A JP2021503235 A JP 2021503235A JP WO2020178878 A1 JPWO2020178878 A1 JP WO2020178878A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021503235A
Other versions
JPWO2020178878A5 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2020178878A1 publication Critical patent/JPWO2020178878A1/ja
Publication of JPWO2020178878A5 publication Critical patent/JPWO2020178878A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2021503235A 2019-03-01 2019-03-01 Pending JPWO2020178878A1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2019/007998 WO2020178878A1 (ja) 2019-03-01 2019-03-01 医薬組成物

Publications (2)

Publication Number Publication Date
JPWO2020178878A1 true JPWO2020178878A1 (ja) 2020-09-10
JPWO2020178878A5 JPWO2020178878A5 (ja) 2022-02-28

Family

ID=72338207

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021503235A Pending JPWO2020178878A1 (ja) 2019-03-01 2019-03-01

Country Status (2)

Country Link
JP (1) JPWO2020178878A1 (ja)
WO (1) WO2020178878A1 (ja)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101961492A (zh) * 2009-07-23 2011-02-02 邬林祥 一种治疗血脂异常的依折麦布复方制剂
JP4886516B2 (ja) * 2004-08-31 2012-02-29 興和株式会社 高脂血症治療剤
JP2013224285A (ja) * 2012-06-27 2013-10-31 Kowa Co 医薬
JP2015074622A (ja) * 2013-10-08 2015-04-20 ダイト株式会社 ピタバスタチンカルシウム塩の分解抑制方法
JP6937195B2 (ja) * 2017-09-01 2021-09-22 興和株式会社 医薬組成物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4886516B2 (ja) * 2004-08-31 2012-02-29 興和株式会社 高脂血症治療剤
CN101961492A (zh) * 2009-07-23 2011-02-02 邬林祥 一种治疗血脂异常的依折麦布复方制剂
JP2013224285A (ja) * 2012-06-27 2013-10-31 Kowa Co 医薬
JP2015074622A (ja) * 2013-10-08 2015-04-20 ダイト株式会社 ピタバスタチンカルシウム塩の分解抑制方法
JP6937195B2 (ja) * 2017-09-01 2021-09-22 興和株式会社 医薬組成物

Also Published As

Publication number Publication date
WO2020178878A1 (ja) 2020-09-10

Similar Documents

Publication Publication Date Title
BR112019017762A2 (ja)
BR112021017339A2 (ja)
BR112021013854A2 (ja)
BR112021017939A2 (ja)
BR112021017892A2 (ja)
BR112019016141A2 (ja)
BR112021017738A2 (ja)
BR112021017782A2 (ja)
BR112019016138A2 (ja)
BR112019016142A2 (ja)
BR112021018168A2 (ja)
BR112021017728A2 (ja)
AU2020104490A5 (ja)
BR112021008711A2 (ja)
BR112021017234A2 (ja)
BR112021017355A2 (ja)
BR112021017173A2 (ja)
BR112021018102A2 (ja)
BR112021017083A2 (ja)
BR112021017637A2 (ja)
BR112021018452A2 (ja)
BR112021012348A2 (ja)
BR112021018250A2 (ja)
BR112021018084A2 (ja)
BR112021018093A2 (ja)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220217

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20220217

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20220217

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220419

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220809